Trademark: 87352573
Word
TEVA
Status Date
Monday, March 29, 2021
Filing Date
Tuesday, February 28, 2017
Published for Opposition
Tuesday, December 26, 2017
Abandoned Date
Monday, March 29, 2021
5 Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system
The color(s) dark green, light green, white and gray is/are claimed as a feature of the mark.
The mark consists of a dark green design that begins at the bottom center and rises up to the upper right hand corner. As the design goes to the upper right hand corner, it fades to a light green and then fades back to a dark green. In the bottom right hand corner is the word "teva" in lower case dark green letters. The "v" in the word "teva" is formed by 2 leaf shapes. The color white also appears in the rectangle created by the gray outlining the entire mark. The entire mark is outlined by a thin gray line.
The English translation of "TEVA" in the mark is "NATURE".
Mar 29, 2021
Abandonment Notice E-Mailed - No Use Statement Filed
Mar 29, 2021
Abandonment - No Use Statement Filed
Aug 22, 2020
Notice Of Approval Of Extension Request E-Mailed
Aug 21, 2020
Extension 5 Granted
Aug 13, 2020
Extension 5 Filed
Aug 18, 2020
Case Assigned To Intent To Use Paralegal
Aug 13, 2020
Teas Extension Received
Feb 29, 2020
Notice Of Approval Of Extension Request E-Mailed
Feb 19, 2020
Extension 4 Granted
Feb 19, 2020
Extension 4 Filed
Feb 19, 2020
Teas Extension Received
Feb 19, 2020
Teas Change Of Correspondence Received
Aug 15, 2019
Notice Of Approval Of Extension Request E-Mailed
Aug 13, 2019
Extension 3 Granted
Aug 13, 2019
Extension 3 Filed
Aug 13, 2019
Teas Extension Received
Feb 15, 2019
Notice Of Approval Of Extension Request E-Mailed
Feb 13, 2019
Extension 2 Granted
Feb 13, 2019
Extension 2 Filed
Feb 13, 2019
Teas Extension Received
Aug 15, 2018
Notice Of Approval Of Extension Request E-Mailed
Aug 13, 2018
Extension 1 Granted
Aug 13, 2018
Extension 1 Filed
Aug 13, 2018
Teas Extension Received
Feb 20, 2018
Noa E-Mailed - Sou Required From Applicant
Dec 26, 2017
Official Gazette Publication Confirmation E-Mailed
Dec 26, 2017
Published For Opposition
Dec 6, 2017
Notification Of Notice Of Publication E-Mailed
Nov 17, 2017
Approved For Pub - Principal Register
Nov 17, 2017
Examiner's Amendment Entered
Nov 17, 2017
Notification Of Examiners Amendment E-Mailed
Nov 17, 2017
Examiners Amendment E-Mailed
Nov 17, 2017
Examiners Amendment -Written
Nov 14, 2017
Teas/Email Correspondence Entered
Nov 14, 2017
Correspondence Received In Law Office
Nov 14, 2017
Teas Response To Office Action Received
May 26, 2017
Notification Of Priority Action E-Mailed
May 26, 2017
Priority Action E-Mailed
May 26, 2017
Priority Action Written
May 23, 2017
Assigned To Examiner
Mar 8, 2017
Notice Of Design Search Code E-Mailed
Mar 7, 2017
New Application Office Supplied Data Entered In Tram
Mar 3, 2017
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
